Acquired Epidermodysplasia Verruciformis Associated with Human Papilloma Virus Type 14 in a Small Bowel Transplanted Child—A Case Report | Zendy

Hirschman Derek | Zendy; Tacastacas Joselin | Zendy; Rady Peter L. | Zendy; Tyring Stephen K. | Zendy; Cooper Kevin | Zendy; Honda Kord | Zendy

Premium

Acquired Epidermodysplasia Verruciformis Associated with Human Papilloma Virus Type 14 in a Small Bowel Transplanted Child—A Case Report

Author(s) -

Hirschman Derek,

Tacastacas Joselin,

Rady Peter L.,

Tyring Stephen K.,

Cooper Kevin,

Honda Kord

Publication year - 2015

Publication title -

pediatric dermatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.542

H-Index - 73

eISSN - 1525-1470

pISSN - 0736-8046

DOI - 10.1111/pde.12734

Subject(s) - epidermodysplasia verruciformis , medicine , imiquimod , tacrolimus , cidofovir , transplantation , dermatology , malignant transformation , organ transplantation , virus , pathology , virology , surgery

A 3‐year‐old African American girl taking sirolimus and tacrolimus for a small bowel transplantation presented with hypopigmented macules and papules throughout her trunk. A biopsy diagnosed epidermodysplasia verruciformis ( EV ) that was found to be associated with human papillomavirus ( HPV ) type 14 according to polymerase chain reaction analysis. There are few cases of acquired EV in the setting of organ transplantation. Although there is no standardized treatment for acquired EV , prevention and surveillance for transformation to squamous cell carcinoma are primary concerns.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research